ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 into First-In-Human Clinical Study
22 août 2019 11h54 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today...
ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 into First-In-Human Clinical Study
22 août 2019 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today...
ONL Therapeutics Names Industry Veteran as CEO as Company Prepares for First in Human Clinical Trials
18 juin 2019 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., June 18, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving vision in a range of retinal diseases, today...
Shareholder Update Q3 2018
02 oct. 2018 00h00 HE
|
Factor Therapeutics
Highlights: Venous leg ulcer Phase 2 trial on track: top-line results mid-NovemberDiabetic foot ulcer pilot clinical study: in development with key US researchersOcular wounds: international patent...
EQUITY ALERT UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Against Ocular Therapeutix, Inc. - OCUL
10 août 2017 18h03 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Ocular Therapeutix, Inc....
Insight Pharma Reports' Gene Therapy Market Report: Moving Toward Commercialization
23 sept. 2016 13h00 HE
|
Insight Pharma Reports
NEEDHAM, MA--(Marketwired - September 23, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, releases "Gene Therapy: Moving Toward Commercialization" an in-depth life science market...
Keynote Speaker and Final Agenda Announced for Targeting Ocular Disorders 2016
02 juin 2016 13h00 HE
|
Cambridge Healthtech Institute
NEEDHAM, MA--(Marketwired - June 02, 2016) - Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, announced the speaker lineup and final agenda for the...
Gene Therapy: Moving Toward Commercialization
11 mai 2016 10h50 HE
|
Insight Pharma Reports
NEEDHAM, MA--(Marketwired - May 11, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, releases "Gene Therapy: Moving Toward Commercialization" an in-depth life science market...